Stock Analysis on Net
Stock Analysis on Net

Boston Scientific Corp. (NYSE:BSX)

This company has been moved to the archive! The financial data has not been updated since May 4, 2023.

Analysis of Short-term (Operating) Activity Ratios

Microsoft Excel

Short-term Activity Ratios (Summary)

Boston Scientific Corp., short-term (operating) activity ratios

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Turnover Ratios
Inventory turnover 2.12 2.30 2.56 1.97 2.41
Receivables turnover 6.44 6.69 6.47 5.87 6.11
Payables turnover 4.59 4.67 6.75 5.75 8.06
Working capital turnover 6.48 5.82 3.29 — —
Average No. Days
Average inventory processing period 172 158 142 185 151
Add: Average receivable collection period 57 55 56 62 60
Operating cycle 229 213 198 247 211
Less: Average payables payment period 80 78 54 64 45
Cash conversion cycle 149 135 144 183 166

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).


The analysis of short-term operating activity ratios reveals a strategic shift in working capital management, characterized by stable receivable collections and a significant extension of supplier payment terms. While inventory management has experienced volatility, the overall efficiency of working capital utilization has improved over the observed period.

Inventory and Receivables Management
Inventory turnover demonstrates fluctuation, reaching a peak of 2.56 in 2020 before declining to 2.12 by 2022. This is mirrored in the average inventory processing period, which varied between 142 and 185 days, suggesting inconsistent inventory throughput. In contrast, receivables management remains highly stable; the receivables turnover ratio stayed within a narrow range of 5.87 to 6.69, with the average collection period remaining consistent between 55 and 62 days.
Payables and Working Capital Efficiency
A pronounced downward trend is observed in payables turnover, which decreased from 8.06 in 2018 to 4.59 in 2022. This shift is reflected in the average payables payment period, which expanded from 45 days to 80 days, indicating a strategic increase in the time taken to settle obligations with suppliers to preserve cash flow. Additionally, working capital turnover shows a strong upward trajectory, increasing from 3.29 in 2020 to 6.48 in 2022, indicating enhanced efficiency in using working capital to generate revenue.
Operating and Cash Conversion Cycles
The operating cycle has shown volatility, peaking at 247 days in 2019 and ending at 229 days in 2022, largely driven by the fluctuations in inventory processing times. Despite this, the cash conversion cycle has been reduced from 166 days in 2018 to 149 days in 2022. The compression of the cash conversion cycle, particularly the drop to 135 days in 2021, was primarily facilitated by the extension of the payables payment period, which effectively offset the duration of the operating cycle.

AI Ask an analyst for more


Turnover Ratios


Average No. Days


Inventory Turnover

Boston Scientific Corp., inventory turnover calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Selected Financial Data (US$ in millions)
Cost of products sold 3,955 3,711 3,465 3,115 2,812
Inventories 1,867 1,610 1,351 1,579 1,166
Short-term Activity Ratio
Inventory turnover1 2.12 2.30 2.56 1.97 2.41
Benchmarks
Inventory Turnover, Competitors2
Abbott Laboratories 3.10 3.59 — — —
Intuitive Surgical Inc. 2.27 2.98 — — —
Medtronic PLC 2.20 2.43 — — —
Inventory Turnover, Sector
Health Care Equipment & Services 30.70 31.85 — — —
Inventory Turnover, Industry
Health Care 7.85 7.90 — — —

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 2022 Calculation
Inventory turnover = Cost of products sold ÷ Inventories
= 3,955 ÷ 1,867 = 2.12

2 Click competitor name to see calculations.


The operational activity related to inventory management between 2018 and 2022 is characterized by steady growth in the cost of products sold, contrasted by fluctuating inventory levels and a volatile turnover ratio. While sales-related costs have risen linearly, the efficiency of inventory utilization has experienced periodic shifts.

Cost of Products Sold Trends
A consistent upward trajectory is observed in the cost of products sold, which rose from 2,812 million US$ in 2018 to 3,955 million US$ by 2022. This steady annual increase suggests a growth in production volume or an increase in the cost of raw materials and manufacturing over the five-year period.
Inventory Level Fluctuations
Inventory balances exhibit a general upward trend but with notable volatility. A significant increase occurred in 2019, reaching 1,579 million US$, followed by a contraction to 1,351 million US$ in 2020. From 2021 onward, inventory levels climbed steadily, ending the period at a peak of 1,867 million US$ in 2022. This indicates a strategic shift toward higher stock levels in the latter part of the analysis period.
Inventory Turnover Performance
The inventory turnover ratio demonstrates instability, fluctuating between a low of 1.97 in 2019 and a high of 2.56 in 2020. The sharp decline in 2019 is attributable to the disproportionate increase in inventory relative to the cost of products sold. Conversely, the peak in 2020 resulted from a reduction in held inventory during a period of rising costs. However, a downward trend is evident from 2020 to 2022, with the ratio falling to 2.12, signaling that inventory accumulation has begun to outpace the growth in product sales costs.

AI Ask an analyst for more


Receivables Turnover

Boston Scientific Corp., receivables turnover calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Selected Financial Data (US$ in millions)
Net sales 12,682 11,888 9,913 10,735 9,823
Trade accounts receivable, net 1,970 1,778 1,531 1,828 1,608
Short-term Activity Ratio
Receivables turnover1 6.44 6.69 6.47 5.87 6.11
Benchmarks
Receivables Turnover, Competitors2
Abbott Laboratories 7.02 6.64 — — —
Elevance Health Inc. 18.81 20.66 — — —
Intuitive Surgical Inc. 6.60 7.30 — — —
Medtronic PLC 5.71 5.51 — — —
UnitedHealth Group Inc. 18.22 20.07 — — —
Receivables Turnover, Sector
Health Care Equipment & Services 14.33 14.76 — — —
Receivables Turnover, Industry
Health Care 8.22 8.00 — — —

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 2022 Calculation
Receivables turnover = Net sales ÷ Trade accounts receivable, net
= 12,682 ÷ 1,970 = 6.44

2 Click competitor name to see calculations.


Net sales exhibited a general upward trajectory from 2018 to 2022, despite a temporary contraction observed in 2020. This growth trend was mirrored by the balance of net trade accounts receivable, which increased from 1,608 million USD in 2018 to 1,970 million USD by the end of 2022. The proportional growth between sales and receivables suggests a consistent application of credit terms throughout the analyzed period.

Receivables Turnover Trends
The receivables turnover ratio remained relatively stable, fluctuating within a range of 5.87 to 6.69. A slight decline occurred between 2018 and 2019, where the ratio dropped from 6.11 to 5.87, indicating a marginal slowdown in the collection of outstanding receivables relative to sales.
Collection Efficiency Improvements
A notable improvement in collection efficiency was recorded between 2019 and 2021, with the turnover ratio climbing to 6.47 in 2020 and peaking at 6.69 in 2021. This upward movement indicates that the organization accelerated its conversion of credit sales into cash during this interval.
Recent Stability and Analysis
In 2022, the turnover ratio experienced a slight moderation to 6.44. Despite this minor decrease from the 2021 peak, the efficiency level remains superior to the figures recorded in 2018 and 2019, suggesting a sustained improvement in the management of operating receivables over the five-year period.

AI Ask an analyst for more


Payables Turnover

Boston Scientific Corp., payables turnover calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Selected Financial Data (US$ in millions)
Cost of products sold 3,955 3,711 3,465 3,115 2,812
Accounts payable 862 794 513 542 349
Short-term Activity Ratio
Payables turnover1 4.59 4.67 6.75 5.75 8.06
Benchmarks
Payables Turnover, Competitors2
Abbott Laboratories 4.15 4.21 — — —
Elevance Health Inc. 7.47 7.59 — — —
Intuitive Surgical Inc. 13.78 14.45 — — —
Medtronic PLC 4.46 4.98 — — —
UnitedHealth Group Inc. 7.26 7.63 — — —
Payables Turnover, Sector
Health Care Equipment & Services 6.94 7.18 — — —
Payables Turnover, Industry
Health Care 5.79 5.84 — — —

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 2022 Calculation
Payables turnover = Cost of products sold ÷ Accounts payable
= 3,955 ÷ 862 = 4.59

2 Click competitor name to see calculations.


The financial data indicates a consistent expansion in operational costs and a concurrent increase in liabilities to suppliers, leading to a deceleration in the rate at which accounts payable are settled over the five-year period.

Cost of Products Sold Trends
A sustained upward trajectory is observed in the cost of products sold, which increased from 2,812 million USD in 2018 to 3,955 million USD in 2022. This reflects a steady growth in the company's direct production expenses throughout the period.
Accounts Payable Evolution
Accounts payable grew significantly from 349 million USD in 2018 to 862 million USD in 2022. Aside from a marginal decrease in 2020, the balance owed to suppliers expanded rapidly, increasing at a rate that exceeded the growth of the cost of products sold.
Payables Turnover Analysis
The payables turnover ratio exhibits a general decline, moving from 8.06 in 2018 to 4.59 in 2022. Although a temporary increase to 6.75 occurred in 2020, the ratio reached its lowest points in 2021 and 2022. This downward trend indicates a lengthening of the payment cycle, suggesting that the company is extending its payment durations or leveraging supplier credit more aggressively to manage working capital.

AI Ask an analyst for more


Working Capital Turnover

Boston Scientific Corp., working capital turnover calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Selected Financial Data (US$ in millions)
Current assets 5,760 6,317 6,694 4,699 4,003
Less: Current liabilities 3,803 4,274 3,681 4,866 5,260
Working capital 1,957 2,043 3,013 (167) (1,257)
 
Net sales 12,682 11,888 9,913 10,735 9,823
Short-term Activity Ratio
Working capital turnover1 6.48 5.82 3.29 — —
Benchmarks
Working Capital Turnover, Competitors2
Abbott Laboratories 4.48 3.87 — — —
Elevance Health Inc. 8.37 7.23 — — —
Intuitive Surgical Inc. 1.29 1.22 — — —
Medtronic PLC 2.97 2.15 — — —
UnitedHealth Group Inc. — — — — —
Working Capital Turnover, Sector
Health Care Equipment & Services 25.59 16.28 — — —
Working Capital Turnover, Industry
Health Care 11.30 8.57 — — —

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 2022 Calculation
Working capital turnover = Net sales ÷ Working capital
= 12,682 ÷ 1,957 = 6.48

2 Click competitor name to see calculations.


An analysis of the operational activity from 2018 to 2022 reveals a significant transition in the management of short-term assets and liabilities, coinciding with a general upward trajectory in revenue generation.

Working Capital Evolution
A notable shift occurred between 2018 and 2020, where working capital moved from a negative position of -1,257 million USD to a positive position of 3,013 million USD. This transition indicates a fundamental change in the liquidity structure, moving from a state where current liabilities exceeded current assets to a position of substantial net current asset availability. Following this peak in 2020, working capital experienced a gradual decline, stabilizing at 1,957 million USD by the end of 2022.
Net Sales Performance
Revenue exhibited a consistent growth pattern over the five-year period, with the exception of a slight contraction in 2020. Net sales increased from 9,823 million USD in 2018 to 12,682 million USD in 2022. The most significant growth phase occurred between 2020 and 2022, where sales rose from 9,913 million USD to 12,682 million USD, representing a strengthening of market activity and top-line performance.
Working Capital Turnover Efficiency
The working capital turnover ratio, which became a meaningful metric once working capital turned positive in 2020, shows a sharp upward trend. The ratio increased from 3.29 in 2020 to 6.48 in 2022. This progression suggests an increase in operational efficiency, as the company generated progressively higher volumes of sales relative to the amount of working capital invested in the business. The doubling of this ratio within two years indicates that the company is utilizing its short-term operating liquidity more effectively to drive revenue growth.

AI Ask an analyst for more


Average Inventory Processing Period

Boston Scientific Corp., average inventory processing period calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Selected Financial Data
Inventory turnover 2.12 2.30 2.56 1.97 2.41
Short-term Activity Ratio (no. days)
Average inventory processing period1 172 158 142 185 151
Benchmarks (no. days)
Average Inventory Processing Period, Competitors2
Abbott Laboratories 118 102 — — —
Intuitive Surgical Inc. 161 122 — — —
Medtronic PLC 166 150 — — —
Average Inventory Processing Period, Sector
Health Care Equipment & Services 12 11 — — —
Average Inventory Processing Period, Industry
Health Care 46 46 — — —

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 2022 Calculation
Average inventory processing period = 365 ÷ Inventory turnover
= 365 ÷ 2.12 = 172

2 Click competitor name to see calculations.


An analysis of the short-term operating activity ratios reveals a fluctuating trend in inventory management efficiency from 2018 through 2022. A consistent inverse correlation is observed between the inventory turnover ratio and the average inventory processing period over this five-year window.

Inventory Turnover
The turnover ratio exhibited significant volatility, starting at 2.41 in 2018 and declining to 1.97 in 2019. A sharp recovery followed in 2020, where the ratio peaked at 2.56. Since this peak, a gradual downward trend has emerged, with the ratio decreasing to 2.30 in 2021 and further to 2.12 by the end of 2022.
Average Inventory Processing Period
The processing period mirrored the turnover fluctuations, increasing from 151 days in 2018 to a high of 185 days in 2019. The most efficient processing cycle was recorded in 2020, with the period dropping to 142 days. However, the subsequent two years show a steady increase in the duration required to process inventory, rising to 158 days in 2021 and reaching 172 days in 2022.

The observed data indicates that after a period of optimized inventory movement in 2020, there has been a gradual decline in operational efficiency. The increase in the processing period from 142 to 172 days suggests a slowing of inventory throughput and a potential increase in the average duration that capital remains tied up in inventory assets.

AI Ask an analyst for more


Average Receivable Collection Period

Boston Scientific Corp., average receivable collection period calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Selected Financial Data
Receivables turnover 6.44 6.69 6.47 5.87 6.11
Short-term Activity Ratio (no. days)
Average receivable collection period1 57 55 56 62 60
Benchmarks (no. days)
Average Receivable Collection Period, Competitors2
Abbott Laboratories 52 55 — — —
Elevance Health Inc. 19 18 — — —
Intuitive Surgical Inc. 55 50 — — —
Medtronic PLC 64 66 — — —
UnitedHealth Group Inc. 20 18 — — —
Average Receivable Collection Period, Sector
Health Care Equipment & Services 25 25 — — —
Average Receivable Collection Period, Industry
Health Care 44 46 — — —

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 2022 Calculation
Average receivable collection period = 365 ÷ Receivables turnover
= 365 ÷ 6.44 = 57

2 Click competitor name to see calculations.


The analysis of short-term operating activity indicates a stable and disciplined approach to accounts receivable management between 2018 and 2022. A consistent inverse correlation is observed between the turnover ratio and the collection period, demonstrating a steady ability to convert credit sales into cash.

Receivables Turnover
The turnover ratio remained relatively stable, fluctuating between a low of 5.87 in 2019 and a peak of 6.69 in 2021. After a slight dip in 2019, an upward trend was observed through 2021, suggesting an increase in the efficiency of credit recovery. The ratio concluded the period at 6.44 in 2022, maintaining a level higher than the 2018 baseline.
Average Receivable Collection Period
The collection cycle exhibited a general downward trend, improving from 60 days in 2018 to 57 days in 2022. A peak in the collection period occurred in 2019 at 62 days, followed by a notable acceleration in 2020 and 2021, where the period reached a minimum of 55 days. The slight increase to 57 days in 2022 suggests a minor relaxation in collection speed, yet the overall efficiency remains superior to the 2018 and 2019 levels.

AI Ask an analyst for more


Operating Cycle

Boston Scientific Corp., operating cycle calculation, comparison to benchmarks

No. days

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Selected Financial Data
Average inventory processing period 172 158 142 185 151
Average receivable collection period 57 55 56 62 60
Short-term Activity Ratio
Operating cycle1 229 213 198 247 211
Benchmarks
Operating Cycle, Competitors2
Abbott Laboratories 170 157 — — —
Intuitive Surgical Inc. 216 172 — — —
Medtronic PLC 230 216 — — —
Operating Cycle, Sector
Health Care Equipment & Services 37 36 — — —
Operating Cycle, Industry
Health Care 90 92 — — —

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 2022 Calculation
Operating cycle = Average inventory processing period + Average receivable collection period
= 172 + 57 = 229

2 Click competitor name to see calculations.


The operating cycle exhibits notable volatility over the observed five-year period, primarily driven by fluctuations in inventory management rather than receivables collection. The overall duration of the cycle has shown a non-linear trend, characterized by a significant peak in 2019, a sharp contraction in 2020, and a subsequent steady increase through 2022.

Average Inventory Processing Period
Inventory management represents the most volatile component of the operating cycle. After an increase to 185 days in 2019, the period dropped to a five-year low of 142 days in 2020. However, a consistent upward trend followed, with the period extending to 158 days in 2021 and reaching 172 days by the end of 2022. This suggests an increase in the time required to convert raw materials and work-in-progress into finished goods and subsequent sales.
Average Receivable Collection Period
The collection of receivables has remained remarkably stable, showing minimal variance compared to inventory levels. The period fluctuated within a narrow range of 55 to 62 days. A slight improvement in efficiency was observed between 2019 and 2021, where the period decreased from 62 to 55 days, before stabilizing at 57 days in 2022. This indicates a consistent and disciplined credit and collections policy.
Operating Cycle Synthesis
The total operating cycle mirrors the movements of the inventory processing period almost exactly, confirming that inventory turnover is the primary determinant of short-term operating liquidity. The cycle peaked at 247 days in 2019 and reached its minimum of 198 days in 2020. As of December 31, 2022, the operating cycle stood at 229 days, reflecting a general lengthening of the cash-to-cash cycle from the 2020 trough.

AI Ask an analyst for more


Average Payables Payment Period

Boston Scientific Corp., average payables payment period calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Selected Financial Data
Payables turnover 4.59 4.67 6.75 5.75 8.06
Short-term Activity Ratio (no. days)
Average payables payment period1 80 78 54 64 45
Benchmarks (no. days)
Average Payables Payment Period, Competitors2
Abbott Laboratories 88 87 — — —
Elevance Health Inc. 49 48 — — —
Intuitive Surgical Inc. 26 25 — — —
Medtronic PLC 82 73 — — —
UnitedHealth Group Inc. 50 48 — — —
Average Payables Payment Period, Sector
Health Care Equipment & Services 53 51 — — —
Average Payables Payment Period, Industry
Health Care 63 63 — — —

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 2022 Calculation
Average payables payment period = 365 ÷ Payables turnover
= 365 ÷ 4.59 = 80

2 Click competitor name to see calculations.


An analysis of the short-term operating activity ratios reveals a persistent trend toward the extension of payment terms to suppliers. Over the observed five-year period, there is a clear correlation between the decline in payables turnover and the increase in the average payables payment period, suggesting a strategic shift in working capital management to retain cash for longer durations.

Payables Turnover Trends
The payables turnover ratio exhibited a general downward trajectory, decreasing from 8.06 in 2018 to 4.59 by the end of 2022. While a temporary increase to 6.75 occurred in 2020, the overall trend indicates a reduction in the frequency with which accounts payable are settled. This decline suggests a slower cycling of payables relative to the cost of goods sold or purchases.
Average Payables Payment Period Analysis
The average payables payment period increased significantly from 45 days in 2018 to 80 days in 2022. A period of volatility was noted between 2019 and 2020, where the duration shifted from 64 days down to 54 days before rising sharply to 78 days in 2021 and 80 days in 2022. This represents an overall increase of 35 days in the average time required to settle supplier obligations.
Working Capital Implications
The widening of the payment period indicates an enhancement in the ability to leverage supplier credit. By extending the payment window from 45 to 80 days, the organization has effectively increased its operating liquidity, utilizing accounts payable as a source of short-term financing to support other operational requirements.

AI Ask an analyst for more


Cash Conversion Cycle

Boston Scientific Corp., cash conversion cycle calculation, comparison to benchmarks

No. days

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Selected Financial Data
Average inventory processing period 172 158 142 185 151
Average receivable collection period 57 55 56 62 60
Average payables payment period 80 78 54 64 45
Short-term Activity Ratio
Cash conversion cycle1 149 135 144 183 166
Benchmarks
Cash Conversion Cycle, Competitors2
Abbott Laboratories 82 70 — — —
Intuitive Surgical Inc. 190 147 — — —
Medtronic PLC 148 143 — — —
Cash Conversion Cycle, Sector
Health Care Equipment & Services -16 -15 — — —
Cash Conversion Cycle, Industry
Health Care 27 29 — — —

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 2022 Calculation
Cash conversion cycle = Average inventory processing period + Average receivable collection period – Average payables payment period
= 172 + 57 – 80 = 149

2 Click competitor name to see calculations.


The analysis of short-term operating activity ratios reveals a dynamic cash conversion cycle driven primarily by fluctuations in inventory management and a strategic extension of payment terms to suppliers. While the overall cycle has experienced volatility, the net efficiency improved from 2018 to 2022, despite a recent upward tick in the final year.

Average Inventory Processing Period
This metric represents the most volatile component of the operating cycle. After a peak of 185 days in 2019, the period declined to 142 days in 2020, before trending upward again to reach 172 days by the end of 2022. These fluctuations indicate significant variability in the speed at which inventory is converted into sales.
Average Receivable Collection Period
Collection efficiency has remained remarkably stable over the five-year period. The timeframe for collecting receivables shifted marginally from 60 days in 2018 to 57 days in 2022, with a low of 55 days in 2021. This stability suggests a consistent and disciplined credit and collections policy.
Average Payables Payment Period
A pronounced upward trend is observed in the time taken to settle obligations with suppliers. The period increased from 45 days in 2018 to 80 days in 2022. This extension of payment terms has served as a critical lever in offsetting the capital tied up in inventory, effectively utilizing supplier credit to improve liquidity.
Cash Conversion Cycle
The total cash conversion cycle peaked at 183 days in 2019 and reached its lowest point of 135 days in 2021. Although the cycle extended to 149 days in 2022, it remains 17 days shorter than the 2018 baseline. The overall reduction in the cycle over the long term is largely attributable to the increase in the payables payment period, which mitigated the impact of rising inventory processing times.

AI Ask an analyst for more